A Rare Presentation of Drug-induced Liver Injury with Fluticasone and Vilanterol Inhaler Use

Drug-induced liver injury (DILI) is a rare and potentially lethal condition associated with the use of many commonly-used medications, including inhaled fluticasone-vilanterol. Therefore, a careful review of medications should always be obtained in the setting of acute onset hepatic dysfunction. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Rishi, Mohit, Wagner, Amanda, Ulanja, Mark, Beutler, Bryce D, Singh, Karmjit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2019
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599465/
https://www.ncbi.nlm.nih.gov/pubmed/31281766
http://dx.doi.org/10.7759/cureus.4933
_version_ 1783430967816355840
author Rishi, Mohit
Wagner, Amanda
Ulanja, Mark
Beutler, Bryce D
Singh, Karmjit
author_facet Rishi, Mohit
Wagner, Amanda
Ulanja, Mark
Beutler, Bryce D
Singh, Karmjit
author_sort Rishi, Mohit
collection PubMed
description Drug-induced liver injury (DILI) is a rare and potentially lethal condition associated with the use of many commonly-used medications, including inhaled fluticasone-vilanterol. Therefore, a careful review of medications should always be obtained in the setting of acute onset hepatic dysfunction. We present the first reported case of idiosyncratic drug-induced liver injury associated with the use of this medication.
format Online
Article
Text
id pubmed-6599465
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-65994652019-07-06 A Rare Presentation of Drug-induced Liver Injury with Fluticasone and Vilanterol Inhaler Use Rishi, Mohit Wagner, Amanda Ulanja, Mark Beutler, Bryce D Singh, Karmjit Cureus Internal Medicine Drug-induced liver injury (DILI) is a rare and potentially lethal condition associated with the use of many commonly-used medications, including inhaled fluticasone-vilanterol. Therefore, a careful review of medications should always be obtained in the setting of acute onset hepatic dysfunction. We present the first reported case of idiosyncratic drug-induced liver injury associated with the use of this medication. Cureus 2019-06-18 /pmc/articles/PMC6599465/ /pubmed/31281766 http://dx.doi.org/10.7759/cureus.4933 Text en Copyright © 2019, Rishi et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Rishi, Mohit
Wagner, Amanda
Ulanja, Mark
Beutler, Bryce D
Singh, Karmjit
A Rare Presentation of Drug-induced Liver Injury with Fluticasone and Vilanterol Inhaler Use
title A Rare Presentation of Drug-induced Liver Injury with Fluticasone and Vilanterol Inhaler Use
title_full A Rare Presentation of Drug-induced Liver Injury with Fluticasone and Vilanterol Inhaler Use
title_fullStr A Rare Presentation of Drug-induced Liver Injury with Fluticasone and Vilanterol Inhaler Use
title_full_unstemmed A Rare Presentation of Drug-induced Liver Injury with Fluticasone and Vilanterol Inhaler Use
title_short A Rare Presentation of Drug-induced Liver Injury with Fluticasone and Vilanterol Inhaler Use
title_sort rare presentation of drug-induced liver injury with fluticasone and vilanterol inhaler use
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599465/
https://www.ncbi.nlm.nih.gov/pubmed/31281766
http://dx.doi.org/10.7759/cureus.4933
work_keys_str_mv AT rishimohit ararepresentationofdruginducedliverinjurywithfluticasoneandvilanterolinhaleruse
AT wagneramanda ararepresentationofdruginducedliverinjurywithfluticasoneandvilanterolinhaleruse
AT ulanjamark ararepresentationofdruginducedliverinjurywithfluticasoneandvilanterolinhaleruse
AT beutlerbryced ararepresentationofdruginducedliverinjurywithfluticasoneandvilanterolinhaleruse
AT singhkarmjit ararepresentationofdruginducedliverinjurywithfluticasoneandvilanterolinhaleruse
AT rishimohit rarepresentationofdruginducedliverinjurywithfluticasoneandvilanterolinhaleruse
AT wagneramanda rarepresentationofdruginducedliverinjurywithfluticasoneandvilanterolinhaleruse
AT ulanjamark rarepresentationofdruginducedliverinjurywithfluticasoneandvilanterolinhaleruse
AT beutlerbryced rarepresentationofdruginducedliverinjurywithfluticasoneandvilanterolinhaleruse
AT singhkarmjit rarepresentationofdruginducedliverinjurywithfluticasoneandvilanterolinhaleruse

Ejemplares similares